Boehringer Ingelheim

Ingelheim am Rhein, Germany, November 10, 2026 Boehringer Ingelheim has announced that the European Medicines Agency’s Committee for Veterinary...

Ingelheim am Rhein, Germany, November 9, 2026 Boehringer Ingelheim has announced positive results from its global Phase III SYNCHRONIZE-CVOT...

Ingelheim, Germany, and Hong Kong, China, November 4, 2026 Boehringer Ingelheim and Sino Biopharmaceutical Limited (SBP Group) have entered...

Ridgefield, Connecticut, United States, October 28, 2026 Boehringer Ingelheim has announced the establishment of its Metabolic Matters Steering Committee,...

FRANKFURT AM MAIN, Germany — September 17, 2026 Merz Therapeutics announced that it has received European Union and European...

INGELHEIM, Germany — September 17, 2026 Boehringer Ingelheim announced the launch of PED Essentials, a free online learning hub...

Ingelheim, Germany, and Bracknell, United Kingdom, September 1, 2026 Boehringer Ingelheim has launched SCOVELLA® (velagliflozin oral solution) in Great...

Toronto, Ontario, Canada, USA 10, 2026 Creyos has announced initial results from its implementation of digital cognitive testing across...

Johns Creek, Georgia, August, USA 10, 2026 Boehringer Ingelheim Animal Health is highlighting the next generation of veterinary researchers...

WASHINGTON, July 16, 2026 Vanda Pharmaceuticals has announced that the Committee for Orphan Medicinal Products (COMP) at the European...